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The Bacillus methanolicus methanol dehydrogenase
(MDH) is a decameric nicotinoprotein alcohol dehy-
drogenase (family III) with one Zn2 ion, one or two
Mg2 ions, and a tightly bound cofactor NAD(H) per
subunit. The Mg2 ions are essential for binding of
cofactor NAD(H) in MDH. A B. methanolicus activator
protein strongly stimulates the relatively low coen-
zyme NAD-dependent MDH activity, involving hydro-
lytic removal of the NMN(H) moiety of cofactor NAD(H)
(Kloosterman, H., Vrijbloed, J. W., and Dijkhuizen, L.
(2002) J. Biol. Chem. 277, 34785–34792). Members of
family III of NAD(P)-dependent alcohol dehydroge-
nases contain three unique, conserved sequence motifs
(domains A, B, and C). Domain C is thought to be in-
volved in metal binding, whereas the functions of do-
mains A and B are still unknown. This paper provides
evidence that domain A constitutes (part of) a new
magnesium-dependent NAD(P)(H)-binding domain.
Site-directed mutants D100N and K103R lacked (most
of the) bound cofactor NAD(H) and had lost all coen-
zyme NAD-dependent MDH activity. Also mutants
G95A and S97G were both impaired in cofactor NAD(H)
binding but retained coenzyme NAD-dependent MDH
activity. Mutant G95A displayed a rather low MDH
activity, whereas mutant S97G was insensitive to acti-
vator protein but displayed “fully activated” MDH re-
action rates. The various roles of these amino acid
residues in coenzyme and/or cofactor NAD(H) binding
in MDH are discussed.
Methanol dehydrogenase (MDH)1 of Bacillus methanolicus
belongs to family III of NAD(P)-dependent alcohol dehydroge-
nases (ADHs) (2, 3), distinct from the zinc-containing medium
chain dehydrogenases/reductases (family I) and the zinc-lack-
ing short chain 32 ADHs (family II) (4, 5). The initial members
of family III all were iron-dependent ADHs. In time, with an
increasing number of member proteins characterized, it be-
came clear that not all members were iron-dependent. Where
investigated, other metals like zinc and magnesium also were
found instead of iron (5). B. methanolicus MDH contains one
Zn2 and one or two Mg2 ions/subunit (3). Identification of
members of family III ADHs increasingly became based on
overall sequence similarity. Three unique, conserved amino
acid sequence motifs have been defined for this family, aiding
in ADH classification (2, 6) (Table I). Over 100 fully sequenced
members of family III ADHs are now found in data bases. Many
of these are putative proteins, with no biochemical data
available.
The genes encoding MDH of B. methanolicus, methanol:p-
nitroso-N,N-dimethylaniline oxidoreductase (MNO) of Amyco-
latopsis methanolica, MNO of Mycobacterium gastri MB19,
ADH of Desulfovibrio gigas, and ADH of Desulfovibrio HDv
enzymes of B. methanolicus, A. methanolica, D. gigas, and
Desulfovibrio HDv have been cloned and characterized by us
(2).2 Classification of the M. gastri enzyme was based on N-
terminal amino acid sequence analysis (Fig. 1A). Characteriza-
tion of the five purified enzymes revealed that each of the
proteins possesses a decameric quaternary structure (7–10).
The first three are nicotinoproteins, containing a tightly but
noncovalently bound NAD(P)(H)/subunit (8, 11). It is unknown
whether other members of family III are nicotinoproteins as
well. The bound NAD(P)(H) species of MDH and A. methan-
olica MNO act as cofactors; they become reduced when the
enzymes oxidize primary alcohols to the respective aldehydes
(8, 11). B. methanolicus MDH requires a second, exogenous
NAD for methanol oxidation, serving as a coenzyme and re-
sulting in reoxidation of the NADH cofactor (11). These two
NAD(H) molecules are not exchanged during the reaction (11).
In vitro, the relatively low coenzyme NAD-dependent MDH
activity is strongly stimulated by a Mr 50,000 activator protein
from the same organism, resulting in a 40-fold increase in the
MDH turnover rate (11, 12).
Activator protein-mediated activation of MDH is charac-
terized by hydrolytic removal of the NMN(H) moiety of cofac-
tor NAD(H) and converts the Ping-Pong type of reaction
mechanism of MDH to a ternary complex mechanism, imply-
ing direct transfer of electrons from methanol to coenzyme
NAD (1). This raises important questions about the binding
and proximity of the coenzyme and cofactor NAD(H) species
in MDH.
The unique, conserved sequence motifs in MDH and other
family III proteins may represent protein domains with impor-
tant functions in substrate or metal binding or in catalysis.
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Domain C (position 258–290) contains several His residues and
is thought to be involved in metal binding (2, 13–15). However,
this remains to be confirmed experimentally. The functions of
the other conserved regions remain unknown. The character-
istic fingerprint of an NAD(P)-binding Rossmann fold,
GXGXX(G/A) (16) (Fig. 1A), is absent in MDH and virtually all
other family III enzymes (2). This dinucleotide-binding consen-
sus motif in the primary structure results in a  fold in the
secondary structure (16). The three Gly residues involved allow
a tight bending between the -helices and -sheets. This en-
ables the dinucleotide to position closely, in the correct confor-
mation, to the protein framework. The coenzyme interacts usu-
ally with a Asp or Glu residue, forming a hydrogen bond with
the 2-OH of the adenosine ribose moiety. In MDH of B. meth-
anolicus and in most other family III ADHs, only an imperfect
fingerprint (G13XG15) is found in the N-terminal part of the
protein (Fig. 1A). Obviously, these enzymes contain strongly
modified or novel NAD(P)(H)-binding domains, allowing bind-
ing of NAD coenzyme in MDH and tight binding of NAD(P)(H)
cofactors in MDH and MNO.
The conserved motif A (GGGSX2DX2K; positions 94–103) in
family III ADHs (Table I and Fig. 1B) displays similarity with
FAD-binding domains, e.g. in alcohol oxidase of Hansenula
polymorpha (DIIVVGGGSX22E) (17, 18). FAD also functions as
a cofactor and remains bound during catalysis, similar to the
NAD(P)(H) cofactors in MDH and MNO enzymes.
Using site-directed mutagenesis, we have modified several
amino acid residues in motif A of MDH. The biochemical prop-
erties of the purified mutant MDHs provide clear evidence that
residues Gly95, Ser97, Asp100, and Lys103 of MDH have impor-
tant roles in binding of NAD(H) coenzyme and/or cofactor.
Surprisingly, mutant S97G lacked bound cofactor NAD(H), was
insensitive to activator protein, but displayed “fully activated”
methanol dehydrogenase reaction rates.
TABLE I
Conserved amino acid sequence motifs for family III NAD(P)-dependent ADHs






FIG. 1. Partial alignment of family III ADHs. A, optimal alignment with the coenzyme NAD-binding consensus sequence proposed by
Wierenga et al. (16). B, alignment with motif A (Table I). AEHBDH, Hydroxybutyrate dehydrogenase of Alcaligenes eutrophus (34); AETDLI,
trans-dienelactoneisomerase of A. eutrophus (35); AMMNO, MNO of A. methanolica2; BCMAR, MAleylacetate reductase of Burkholderia cepacia
(36); BMMDH, MDH of B. methanolicus (2); CAADH, ADHI of Clostridium sp. NCP262 (37); CAADHEC, aldehyde/alcohol dehydrogenase of
Clostridium acetobutylicum (38); CABDHI, butanol dehydrogenase I of C. acetobutylicum (39); CABDHII, butanol dehydrogenase II of
C. acetobutylicum (39); CFDHAT, 1,3-propanediol dehydrogenase of Citrobacter freundii (40); CKHBDH, Hydroxybutyrate dehydrogenase of
Clostridium kluyveri (41); DGADH, ADH of D. gigas (9); HDvADH, ADH of Desulfovibrio HDv (10); EC387, gene product 382 of E. coli (accession
number U28377); ECADHC, alcohol/acetaldehyde dehydrogenase of E. coli (42); ECPOR, 1,3-propanediol dehydrogenase of E. coli (43); ECYIAY,
putative gene product of E. coli (44); EHADH, ADH of Entamoeba histolytica (accession number S41377); EHPADH, gene product of E. histolytica
(45); KPPOR, 1,3-propanediol dehydrogenase of Klebsiella pneumoniae (accession number U30903); MGMNO, MNO of M. gastri MB19 (8);
PSTDLI, trans-dienelactoneisomerase of Pseudomonas sp. strain P51 (46); RHTHCE, thcE gene product of Rhodococcus NI86/21 (47); SCADH4,
ADH IV of Saccharomyces cerevisiae (48); SPADH, ADH of Schizosaccharomyces pombe (accession number Q09669); STEUP, ethanolamine
utilization protein of Salmonella typhimurium (49); THERMADH, ADH of Thermococcus strain AN1 (50); ZMADHII, ADH II of Z. mobilis (51).
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Bacterial Strains and Growth Conditions—Escherichia coli strain
DH5, serving as host for genetic modifications and heterologous gene
expression, was grown on LB medium (19), and appropriate ampicillin
(100 mgliter1) was added. Plasmid pMDH was constructed using
pBlueScript KS and the B. methanolicus MDH encoding gene, ex-
pressed from its own promoter (2).
Expression of MDH (mutant) proteins in E. coli DH5 (cMDH) grown
on LB medium (LB) or LB medium supplemented with 20 mM MgSO4
(LBMg) was performed overnight. The addition of MgSO4 to the
growth medium was previously shown to be essential for Mg2 and
cofactor NAD(H) binding in MDH protein expressed in E. coli, also
determining the sensitivity of MDH to the stimulatory effect of activa-
tor protein, resulting in hydrolytic removal of the NMN(H) moiety of
cofactor NAD(H) (1).
Secondary Structure Prediction—The secondary structure of MDH
was predicted with the Profile prediction program provided by EMBL
Heidelberg (20).
Site-directed Mutagenesis—Mutations were introduced with PCR us-
ing VENT-DNA polymerase (New England Biolabs). With plasmid
pMDH serving as template DNA, a first PCR was performed with a
mutagenesis sense primer and antisense primer R (Fig. 2). The PCR
product obtained was used as primer in a second PCR, together with
primer L1 (in the case of D88N, G95A, S97G, S97T, D100N, and K103R)
or L2 (in the case of G13A and G15A) (Fig. 2). The product of the final
PCR was digested with NsiI and exchanged with the original NsiI
fragment of pMDH, resulting in a plasmid encoding a mutant MDH.
Construction of mutants G13A and G15A involved exchange of the
SwaI-NdeI fragment (Fig. 2).
The desired mutants were constructed using the mutagenesis prim-
ers listed in Fig. 2. Also depicted in this figure are the new restriction
sites introduced by silent mutations that were used for rapid screening
of potential mutants. All of the mutations were confirmed by determin-
ing the full nucleotide sequences of the mutant genes.
DNA Sequencing—Nucleotide sequencing was done using dye prim-
ers in the cycle sequencing method (21) with the thermosequenase kit
RPN 2538 from Amersham Biosciences. The samples were run on the
A.L.F-Express sequencing robot. Analysis of nucleotide sequence was
done using CloneManager, version 4.01.
Enzyme Assays—All of the assays were performed at 50 °C using
prewarmed buffer solutions. The oxidation or reduction of NAD(H) was
followed at 340 nm. The MDH assay contained enzyme, 100 mM glycine/
KOH, pH 9.5, 5 mM MgSO4, 5 mM -mercaptoethanol, and 1 mM NAD
;
after 3 min of preincubation, the reaction was started with 500 mM
methanol (7). Saturating amounts of purified B. methanolicus activator
protein (1) were added to analyze its stimulating effect on MDH activ-
ity. The low coenzyme NAD-dependent activity of MDH with C1–C4
primary alcohols is strongly stimulated by activator protein, provided
MDH contains NAD(H) cofactor and Mg2 ions are present in the assay
mixture (1, 12). The formaldehyde reductase (FoRed) assay contained
enzyme, 50 mM potassium phosphate, pH 6.7, and 0.15 mM NADH;
after 3 min of preincubation, the reaction was started with 10 mM
formaldehyde (7).
Protein Purification—Wild type and mutant MDHs were purified as
described (2), with some modifications (Table II). Overnight cultures of
E. coli (pMDH) were grown on LB medium alone or LB medium sup-
plemented with 20 mM MgSO4 (LBMg) (1) and were harvested by
centrifugation; the cells were disrupted by two passages through a
French pressure cell at 140 megapascals. The crude extracts were
prepared by centrifugation for 30 min at 40,000  g. The proteins were
partially precipitated by adding ammonium sulfate to 30% saturation
followed by incubation on ice for 10 min. After centrifugation (10 min at
25,000  g), the supernatant was applied on a phenyl Superose (hydro-
phobic interaction) column equilibrated with 20% (w/v) (NH4)2SO4 in
buffer A (50 mM Tris/HCl, 5 mM MgSO4, 5 mM -mercaptoethanol, pH
7.5). The proteins were eluted with a gradient of 20–0% (w/v)
(NH4)2SO4. The active fractions were pooled, desalted on PD-10 col-
umns (Sephadex G-25 M; Amersham Biosciences), and applied on a
Mono Q (anion exchange) column; the proteins were eluted with a 1–0
M KCl gradient in buffer A. Inactive mutants were purified in the same
way; the fractions were pooled at the same concentration of the salt
gradients as wild type MDH.
Protein Determination—The protein concentrations were determined
with a Bio-Rad protein determination kit using bovine serum albumin
as a standard (22). SDS-PAGE was performed as described by Laemmli
and Favre (23). The gel was stained with Coomassie Brilliant Blue
R250.
Kinetic Studies—Enzyme kinetics were studied using standard assay
conditions and varying substrate concentrations. The data were fitted
with Sigma Plot for Windows 4.0 (Jandell Scientific Software) according
to the Michaelis-Menten equation. The effect of the activator protein
was determined by adding 5 g of purified protein (1).
Presence of Cofactor NADH—The presence of NADH cofactor in
(mutant) MDH proteins purified from E. coli was analyzed by cofactor
extraction. Purified MDH protein (1–2 mg) was denatured by boiling for
2 min in the presence of 6 M urea (11), and subsequently denatured
protein was separated from NADH on a Pharmacia PD-10 column,
equilibrated with 10 mM Tris/HCl, pH 8.0, containing 6 M urea (buffer
B). The first ml of the salt fraction (containing NADH) supplemented
with 2 ml of buffer B to decrease salinity was applied on a Mono Q
column equilibrated with buffer B and eluted in a gradient of 0–1 M KCl
in buffer B. A solution of 10 nmol of NADH was treated in the same way
and served as standard.
Molecular Modeling—Molecular modeling of known protein three-
dimensional structures was performed with the Swiss-PdbViewer pro-
gram, version 3.6b3, Glaxo Wellcome Experimental Research.
RESULTS
Selection of MDH Mutants—Analysis of the secondary struc-
ture of MDH using Profile network prediction Heidelberg (20)
revealed a repetition of -helices and -sheets in the first 140
N-terminal amino acids. The C-terminal part of MDH consists
mainly of -helices and lacks -sheets. The imperfect NAD
binding fingerprint around Gly13 and Gly15 present in the N
terminus of MDH and in many other family III ADHs (Fig. 1A)
does show a  type of fold. Also the domain with the con-
served motif A shows a similar succession of -helices and
-sheets; this is not the case for the conserved B and C motifs.
The G13A and G15A mutants were constructed to analyze
FIG. 2. A, outline of site-directed mutagenesis strategy of the MDH
gene of B. methanolicus. A detailed description is given under “Mate-
rials and Methods.” B, sequences of PCR primers used for site-directed
mutagenesis of MDH. The mutated nucleotides and amino acids are
printed in bold type, and the resulting restriction sites are underlined.
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the possible role of the imperfect NAD-binding fingerprint
(GXG). A number of amino acids constituting motif A were
selected as targets for mutagenesis, based on the predicted
functions for these residues in known binding motifs. Thus,
Asp88 or Asp100 may have a direct interaction with the 2-OH of
the adenosine ribose moiety of NAD. Gly95 may be essential
for a proper arrangement of the -helix and -sheets, which
enables a close approach of the cofactor/coenzyme to the protein
framework and catalytic residues. Lys103 and Ser97 were cho-
sen because of their high degree of conservation within mem-
bers of family III (Fig. 1B). To avoid drastic conformational
changes, amino acids were replaced by residues of almost the
same size, except for the Gly mutations where spherical hin-
drance was intended. This resulted in the following mutants:
G13A, G15A, D88N, G95A, S97G, S97T, D100N, and K103R.
The genes encoding these mutant MDHs were completely se-
quenced, confirming that only the intended, single amino acid
substitutions had occurred. Any differences in MDH properties
therefore could be attributed to primary or secondary effects of
the single amino acid modifications.
Purification of (Mutant) MDH Proteins—Mutant MDH pro-
teins were expressed in E. coli grown on LB and LBMg
medium to study the effect of Mg2 on the kinetics of the
(mutant) proteins, because it was previously shown that Mg2
has a profound effect on MDH cofactor NAD(H) binding. Puri-
fied MDH expressed in E. coli (cMDH) in the absence of addi-
tional Mg2 in growth medium lacks cofactor NAD(H), whereas
the addition of 20 mM MgSO4 yields MDH protein containing
NAD(H) cofactor, similar to MDH expressed in B. methanolicus
(bMDH) (1).
SDS-PAGE analysis of crude extracts revealed the dominant
MDH band at 43 kDa in all samples. MDH proteins were
purified in three steps. For every mutant the purification fold
was about three times, whereas the yield was 35%. The
purity of all purified enzymes, estimated by SDS-PAGE,
ranged from 98% to near electrophoretic homogeneity. The
purification of wild type MDH from E. coli provides a repre-
sentative example (Table II).
Characterization of Mutant MDH Enzymes—The MDH and
the FoRed activities of purified (mutant) MDH proteins were
kinetically characterized (Table III). Mutants G15A and D88N
showed minor differences with wild type MDH (not shown).
These residues thus do not play an important role in MDH or
FoRed activities. G13A displayed clearly reduced MDH and
FoRed activities, most likely because of reduced protein stabil-
ity. Mutants D100N and K103R completely lacked MDH and
FoRed activities, both in crude extracts and in purified prepa-
rations. These proteins were purified following the elution pro-
files of active enzymes; purification was confirmed by SDS-
PAGE. Analysis of crude extracts of both inactive mutants on
SDS-PAGE showed a normal level of expression, comparable
with other mutants and wild type protein.
Compared with bMDH and cMDH, mutant G95A expressed
in E. coli cells grown on LBMg displayed substantially (10-
fold) decreased affinity for coenzyme NAD and NADH and a
strongly reduced Vmax for both MDH and FoRed. Expression of
mutant G95A in E. coli cells grown on LB medium resulted in
an even more reduced substrate affinity. When increasing the
assay NAD concentration, the very low MDH activity of G95A
continued to increase almost proportionally. Kinetic parame-
ters could therefore not be estimated properly in this case. The
same was true for the FoRed reaction; increasing amounts of
NADH resulted in a linear increase of activity (not shown) and
failure to calculate kinetic parameters.
Compared with cMDH, mutant S97G displayed drastically
increased MDH activity. Although the Vmax increased more
than 10 times, the affinity for coenzyme NAD decreased more
than 30-fold (Table III). Absence of Mg2 in the growth medium
of E. coli cells producing mutant S97G protein resulted in
reduced Vmax and coenzyme NAD(H) affinity values for both
MDH and FoRed. With respect to the effect of Mg2, basically
the same observations were made with the S97T mutation,
although the changes were less extreme than in mutant S97G.
This mutant displayed Vmax values similar to those of cMDH,
whereas its affinity constants for coenzyme NADH were inter-
mediate to those of cMDH and S97G.
The activator protein strongly stimulates MDH (but not
FoRed) activity of the B. methanolicus bMDH protein (12).
Activity of cMDH (when purified from E. coli cells grown on
LBMg medium) also was stimulated about 8-fold when add-
ing saturating amounts of activator protein. cMDH purified
from E. coli cells grown on LB medium was only slightly stim-
ulated in activity by activator protein (Table III). Regardless of
the addition of Mg2 ions, mutants G95A and S97G were
completely insensitive to the stimulating effect of the activator
protein on MDH activity. Mutant S97G, although insensitive to
activator protein, displayed fully activated MDH reaction
rates, albeit with a clearly reduced NAD affinity. The inactive
mutants D100N and K103R remained inactive after the addi-
tion of activator protein. In contrast, the activity of mutant
S97T, purified from E. coli cells grown on LBMg medium, was
stimulated again by activator protein (by a factor 5.5). All other
MDH mutants (G13A, G15A, and D88N) responded to activator
protein as cMDH (Table III; data not shown).
Presence of Cofactor in (Mutant) MDH Proteins—To estab-
lish the presence of cofactor NAD(H) in (mutant) MDHs, urea
extracts of MDH proteins purified from E. coli cells grown on
LB and LBMg medium were analyzed, using Mono Q anion
exchange chromatography (Fig. 3). No, or very little, A260 ab-
sorption was detected with wild type and mutant MDH pro-
teins purified from cells grown on LB medium; as previously
shown the presence of Mg2 ions in the medium is essential for
the binding of cofactor NAD(H) in MDH (1). Using proteins
purified from LBMg grown cells, the elution profiles of the
cofactor fractions of wild type MDH (2 mg) and mutant S97T
(1.6 mg) clearly showed absorbance peaks at 260 nm, corre-
sponding to NADH. A similar amount of S97G protein (1.5 mg)
was used for urea treatment, but in this case an A260 absorp-
tion peak was nearly absent in the elution profile. The elution
profiles of G95A, D100N, and K103R (the amounts of protein
used were 1.2, 1.0, and 1.1 mg, respectively) revealed a strongly
reduced (mutant D100N) or virtually absent A260 absorption
TABLE II
Purification of wild type MDH expressed in E. coli cells grown on LB medium
Sample Protein Specific activity Total activity Yield Purification
mg millunits/mg millunits % fold
Crude extract 22.8 165 3760 100 1.0
AS precipitationa 17.3 235 4050 107 1.4
Phenyl Superose 6.7 332 2240 60 2.0
PD-10 8.4 294 2460 65 1.8
Mono Q 3.4 413 1380 37 2.5
a AS, ammonium sulfate.
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(mutants G95A and K103R). The data thus clearly indicate
that only S97T and D100N still bind cofactor NADH, whereas
mutants G95A, S97G, and K103R lack bound NADH or contain
only minor amounts. Cofactor NADH was quantified by peak
integration (Table III).
Steady-state Kinetics of cMDH-WT and cMDH-S97G—MDH
purified from B. methanolicus (bMDH) obeys a Ping-Pong type
of reaction mechanism, in which the NAD(H) cofactor is used as
a temporary electron sink (11). Ping-Pong mechanisms are
characterized by alternate binding of substrate and release of
product. cMDH expressed under conditions in which cofactor
NADH binding is poor displays a ternary complex type of
reaction mechanism (1). In the absence of a temporary electron
sink (cofactor NADH), the reaction will proceed only when both
substrates (methanol and coenzyme NAD) are bound to the
enzyme. The kinetics of MDH mutants lacking the capacity to
bind NAD(H) cofactor was further analyzed.
Steady-state MDH reaction rates with varying NAD con-
centrations at different methanol concentrations were deter-
mined for cMDH and mutant S97G. Hanes plots of cMDH
expressed in E. coli grown on LBMg medium clearly revealed
lines intercepting the vertical axis, indicating uncompetitive
cosubstrate inhibition, which is typical for a Ping-Pong type of
reaction mechanism. Mutant S97G, however, revealed a mixed
noncompetitive cosubstrate inhibition, indicating either a ter-
nary complex or a Theorell-Chance reaction mechanism (24,
25). Absence of cofactor NAD(H) binding thus leads to a ternary
complex reaction mechanism in mutant S97G.
DISCUSSION
The data show that Gly13 and Gly15 in the N-terminal part of
the protein containing the imperfect NAD-binding fingerprint
are not involved in binding of cofactor or coenzyme NADH.
These mutant enzymes showed normal characteristics, al-
though mutant G13A displayed decreased Vmax values for
MDH and FoRed, most likely because of reduced protein sta-
bility. Also mutant D88N displayed no significant differences
with wild type MDH.
Mutants D100N and K103R had completely lost MDH and
FoRed activities, both in crude extracts and in purified protein
preparations. These proteins displayed a normal mobility on
SDS-PAGE with no indications for reduced protein stability.
Mutant K103R had completely lost cofactor NADH, whereas in
mutant D100N about 40% of the cofactor-binding sites were
occupied (Fig. 3 and Table III). However, the cofactor bound to
D100N is apparently not functional. In other enzymes with the
GXGXXG fingerprint motif, an Asp residue is directly involved
in binding of NAD(P)(H) (16, 26). Also Lys is a common con-
served residue in these NAD(P)(H)-binding sites (26), but its
role is unknown. Our data provide evidence that Asp100 and
TABLE III
Kinetic characteristics and cofactor NADH content of wild type B. methanolica (bMDH), wild type (cMDH), and mutant MDH enzymes
expressed in E. coli





contentMDH FoRed NAD NADH
milliunits/mg mM NAD(H) %
bMDH NAb 1310 5950 0.02c 0.009 8.5 100
cMDH Mg 390 2100 0.04 0.010 1.9 NDd
Mg 910 4750 0.03 0.011 8.1 100
S97G Mg 7780 3000 2.5 0.04 1.1 ND
Mg 10400 11730 0.99 0.026 1.3 4
G95A Mg 220e 2300e ND ND 0.7 ND
Mg 100 920 0.51 0.11 0.6 7
S97T Mg 730 2100 0.2 0.02 1.6 ND
Mg 750 4170 0.04 0.017 5.5 71
D100N Mg 0 0 ND ND — ND
Mg 0 0 ND ND — 41
K103R Mg 0 0 ND ND — ND
Mg 0 0 ND ND — 1
a Stimulating effect of activator protein: factor by which MDH activity is changed as a result of addition of activator protein; —, no effect.
b NA, not applicable.
c Affinity of bMDH for coenzyme NAD decreased to 190 M in the presence of activator protein (12).
d ND, not determined.
e MDH and FoRed activities of G95A (Mg2) increased almost linearly with increasing substrate concentrations; the values given are with
2.5 M methanol and 0.1 M formaldehyde.
FIG. 3. Elution profiles of MDH wild type and mutant cofactor
NAD(H) fractions on a Mono Q anion exchange column. The
amounts of protein used for denaturation were as follows: MDH (2 mg),
G95A (1.2 mg), S97G (1.5 mg), S97T (1.6 mg), D100N (1 mg), and K103R
(1.1 mg). The elution profile of NADH (10 nmol) is used as reference.
The dotted line represents the KCl concentration in the buffer.
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Lys103 are essential residues for MDH cofactor NAD(H)
binding.
Mutants G95A and S97G contained no or very little cofactor
NADH, indicating that the Gly95 and Ser97 residues are also
very important for cofactor NAD(H) binding. Speculatively, the
hydroxyl group of Ser97 may form a hydrogen bond with cofac-
tor NAD(H). Mutant S97T, only slightly affected in binding of
cofactor NADH (Table III), apparently is still able to form the
same hydrogen bond, whereas mutant S97G, lacking this hy-
droxyl group, has completely lost this hydrogen bonding ability
and thus lacks cofactor NADH binding. A Ser residue is also
essential in the (unrelated) cofactor NADP(H)-binding site of
glucose:fructose oxidoreductase of Zymomonas mobilis. Glu-
cose:fructose oxidoreductase mutant protein S116D was shown
to lack tightly bound NADP(H) cofactor (27, 28). Determination
of the three-dimensional structure of glucose:fructose oxi-
doreductase revealed that Ser116 (Ser64 in the mature protein)
is involved in hydrogen bonding with the 2-phosphate group of
the NADP(H) cofactor (29). These results clearly demonstrate
that mutational loss of one specific residue, among the several
residues involved in cofactor binding, already may result in the
complete loss of cofactor NAD(H).
Coenzyme NAD affinity was drastically decreased in mu-
tant S97G. Loss of cofactor NAD(H) thus also strongly affects
coenzyme NAD binding in mutant S97G. The same phenom-
enon was observed in mutant S97T, purified from E. coli cells
grown in the absence of Mg2. However, expression of mutant
S97T in E. coli grown on LBMg medium restored cofactor
NAD(H) binding and sensitivity to activator protein; this pro-
tein displayed a coenzyme NAD affinity similar to that of the
cMDH and bMDH proteins (Table III). In conclusion, 1) the
presence of Mg2 ions in the growth medium (and in MDH
protein) is crucial for cofactor NAD(H) binding; this involves a
new magnesium-dependent NAD(H)-binding domain with the
Gly95, Ser97, Asp100, and Lys103 amino acid residues (2). The
stimulatory effect of activator protein on MDH activity is de-
pendent on the presence of cofactor NAD(H) (3). The cofactor
NAD(H)-binding site is (only mildly) affected by mutation S97T
but not the coenzyme NAD-binding site; mutants G95A and
S97G have entirely lost cofactor NAD(H) binding and display
reduced affinity for coenzyme NAD (Table III). These data are
taken to indicate that in wild type MDH, cofactor NAD(H) and
coenzyme NAD bind in close proximity and that mutations
strongly reducing cofactor NAD(H) binding also affect coen-
zyme NAD binding (mutants G95A and S97G). Conceivably,
in MDH mutants G95A and S97G, the cofactor NAD(H)-bind-
ing site still has (a decreased) affinity for NAD(H) and now
functions as a coenzyme NAD-binding site. With the cofactor
NAD(H)-binding site positioned ideally toward the active site,
reducing equivalents may be rapidly transferred to coenzyme
NAD, now present in the cofactor NAD(H)-binding site. This
results in low MDH activity in mutant G95A, with a very low
affinity for coenzyme NAD (Table III). In contrast, a much
higher MDH reaction velocity is observed for mutant S97G
(Table III), most likely because of proper binding of coenzyme
NAD in the cofactor NAD(H)-binding site and because no
transfer of reducing equivalents from cofactor NAD(H) to coen-
zyme NAD is necessary, previously shown to be the rate-
limiting step in the overall MDH reaction cycle (11).
The hypothesis that in mutants devoid of tightly bound co-
factor NAD(H), coenzyme NAD-dependent MDH activity pro-
ceeds via coenzyme NAD binding in the cofactor NAD(H)-
binding site is supported by several further observations. First,
the results show that Mg2 has a profound effect on cofactor
binding of cMDH and mutant S97T, emphasizing its function
in the cofactor NAD(H)-binding site. In mutants S97G and
G95A the presence of Mg2 leads to an increased coenzyme
NAD affinity (Table III), indicating that coenzyme NAD is
FIG. 4. Model of the coenzyme NAD- and cofactor NAD(H)-binding site of MDH.
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bound in the Mg2-dependent cofactor NAD(H)-binding site.
Second, (mutant) proteins equipped with cofactor (cMDH and
S97T expressed in LBMg, and bMDH) share equivalent co-
enzyme NAD affinities, indicating that the coenzyme site is
unaffected by the S97T mutation. Residue Ser97 thus is not
part of the coenzyme-binding site. In mutant enzymes devoid of
cofactor NAD(H), the coenzyme NAD affinity has become
reduced by at least 1 order of magnitude, which indicates that
an alternative binding site is employed. Third, it is more plau-
sible to assume that mutants D100N and K103R are unable to
bind coenzyme NAD in the cofactor NAD(H)-binding site,
yielding inactive and (partly) cofactor NAD(H) deficient mu-
tants, than to speculate that in both mutants a single amino
acid change leads to binding deficiency in both cofactor and
coenzyme-binding sites.
Wild type MDH displays a Ping-Pong type of reaction mech-
anism, with the cofactor functioning as a temporary electron
sink. MDH expressed in LB medium and MDH mutants lack-
ing the capacity to bind cofactor NAD(H) thus are expected to
change from a Ping-Pong type of reaction mechanism to a
ternary complex reaction mechanism. This is clearly confirmed
by the cosubstrate inhibition patterns of cMDH containing
cofactor NAD(H) and mutant S97G lacking cofactor NAD(H),
with the former displaying uncompetitive cosubstrate inhibi-
tion typical for a Ping-Pong type reaction mechanism and the
latter showing mixed noncompetitive cosubstrate inhibition,
indicating either a ternary complex or a Theorell-Chance reac-
tion mechanism (24, 25).
The results presented above combined with our studies on
the mechanism of activator protein mediated activation of
MDH (1) enabled us to develop a model of the cofactor NAD(H)-
binding domain of MDH (Fig. 4). Basically, a MDH molecule
can occur in two states: the nonactivated state and the acti-
vated state. Nonactivated MDH exhibits a Ping-Pong type of
reaction mechanism, in which reducing equivalents are trans-
ferred from methanol via cofactor NAD(H) to coenzyme NAD,
requiring both sites to be in close proximity of each other.
Activator protein-mediated activation of MDH is characterized
by hydrolytic removal of the NMN(H) moiety of cofactor
NAD(H) and converts the reaction mechanism of MDH to a
ternary complex mechanism, implying direct transfer of elec-
trons from methanol to coenzyme NAD (1). In this situation
the NMN moiety of coenzyme NAD, being in close proximity
of the cofactor NAD(H)-binding site, moves into the partially
vacant cofactor NAD(H)-binding site. Activator protein belongs
to the family of Nudix (nucleotide diphosphate linked to some
other moiety X) hydrolases (30). One member of this protein
family, MutT of E. coli, requires two divalent cations for catal-
ysis, both positioned toward the pyrophosphate moiety of its
substrate (8-oxo)-dGTP (31). The action of activator protein on
cofactor NAD(H) most likely proceeds via an analogous mech-
anism, requiring two Mg2 ions positioned toward the pyro-
phosphate group of cofactor NAD(H), the first being the MDH-
bound Mg2 ion (Fig. 4) and the second being an external Mg2
ion, because MDH activation by activator protein requires ex-
ternal Mg2 ions.
Because of the loss of high affinity NAD(H) binding in the
cofactor-binding site of mutant S97G, it may now function as a
coenzyme NAD-binding site. Although binding of coenzyme
NAD in mutant S97G is different from that in activated MDH
(Fig. 4), the (ternary complex) reaction mechanism is similar,
also leading to a fully activated MDH, with a very high coen-
zyme NAD-dependent MDH activity. Although mutant G95A
is also cofactor-deficient and is characterized by the same re-
action mechanism, the additional methyl group may introduce
sterical hindrance, thereby preventing the coenzyme to posi-
tion well in the cofactor-binding site, leading to a decrease in
Vmax of the NAD
-dependent MDH activity. The inactivity of
cofactor-deficient mutants D100N and K103R could indicate
that residues Asp100 and Lys103 are involved in binding of the
important redox active NMN(H) group of cofactor NAD(H) or,
in case of MDH in the activated state, with the NMN(H) moiety
of the coenzyme NAD (Fig. 4).
Recently, the crystal structure of coenzyme NAD-depend-
ent glycerol dehydrogenase (GlyDH) of Bacillus stearother-
mophilus was solved (32). This protein, which is 23% identical
and 40% similar to MDH, partly contains the conserved motif A
of family III ADHs, but with a Lys residue at the position of the
Ser97 residue of MDH. In GlyDH it was shown that the three
Gly residues interact with the pyrophosphate moiety of coen-
zyme NAD. Lys97 of GlyDH interacts with the nicotinamide
ribose, whereas Asp100, together with eight other residues,
forms a deep binding pocket for the nicotinamide ring. Asp100
forms hydrogen bonds with the carboxyamide nitrogen atom of
the nicotinamide ring of NAD(H) (Fig. 4).
It thus appears that the cofactor NAD(H)-binding site of
MDH described in this study is similar to the coenzyme NAD-
binding site of GlyDH, adding further support for our sugges-
tion that mutant S97G uses the cofactor NAD(H)-binding site
as a coenzyme NAD-binding site. The structure of GlyDH also
provided an explanation for the deleterious effect of the K103R
mutation; modeling of the K103R in the GlyDH structure
showed that Arg103 causes steric hindrance for the Asp100 res-
idue, interfering with binding of Asp100 to the nicotinamide
group.
The availability of E. coli-B. methanolicus shuttle vectors
and a suitable transformation system for B. methanolicus
strains (33) yields interesting opportunities for further in vivo
analysis of mutant MDHs lacking cofactor NAD(H). Several
residues of the conserved motif in domain A of family III ADHs
thus are indeed involved in binding of cofactor/coenzyme
NAD(H). It remains to be studied whether tight binding of
NAD(P)(H) cofactors is a lot more widespread in family III
ADHs.
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